Bristol Myers’ Celgene gamble, Apple’s IPR attack on Qualcomm, 2018’s US patent litigation stats, key CRISPR facts, plus much more – IAM

Bristol Myers’ Celgene gamble, Apple’s IPR attack on Qualcomm, 2018’s US patent litigation stats, key CRISPR facts, plus much more  IAM

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week – as well as links to each one.